MARQ3 Trademark

Trademark Overview


On Wednesday, October 9, 2024, a trademark application was filed for MARQ3 with the United States Patent and Trademark Office. The USPTO has given the MARQ3 trademark a serial number of 98792674. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 23, 2025. This trademark is owned by Pegasus Laboratories, Inc.. The MARQ3 trademark is filed in the Pharmaceutical Products category with the following description:

Gauze for dressings, vitamin and mineral supplements for veterinary purposes; animal health care products, namely, nutritional supplements; animal wound care products, namely, a healing gel being a hemostatic gel matrix preparation for treating wounds; post-operative and trauma management dressing for veterinary purposes, namely, wound dressings for post-operative and trauma management for animals; veterinary eye drops; bacteriological preparations for veterinary purposes; enema preparations for veterinary purposes; anti-diarrheal demulcent medicine for veterinary purposes; nutritional supplements for treating gastric disorders and to promote enteric health for veterinary purposes; antiseptic preparations for veterinary purposes; veterinary preparations for animal healthcare, namely, oral iodine, vitamin, and mineral supplements in bolus form for equine and bovine; veterinary pharmaceutical, namely, a pharmaceutical preparation for the treatment of incontinence in dogs; animal health c...
marq3

General Information


Serial Number98792674
Word MarkMARQ3
Filing DateWednesday, October 9, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 23, 2025

Trademark Statements


Pseudo MarkMARQ 3; MARQTHREE; MARQ THREE; MARK3; MARK 3; MARK THREE; MARKTHREE
Goods and ServicesGauze for dressings, vitamin and mineral supplements for veterinary purposes; animal health care products, namely, nutritional supplements; animal wound care products, namely, a healing gel being a hemostatic gel matrix preparation for treating wounds; post-operative and trauma management dressing for veterinary purposes, namely, wound dressings for post-operative and trauma management for animals; veterinary eye drops; bacteriological preparations for veterinary purposes; enema preparations for veterinary purposes; anti-diarrheal demulcent medicine for veterinary purposes; nutritional supplements for treating gastric disorders and to promote enteric health for veterinary purposes; antiseptic preparations for veterinary purposes; veterinary preparations for animal healthcare, namely, oral iodine, vitamin, and mineral supplements in bolus form for equine and bovine; veterinary pharmaceutical, namely, a pharmaceutical preparation for the treatment of incontinence in dogs; animal health care products, namely, protein supplements, vitamin supplements and mineral supplements; calcium phosphorus magnesium and potassium supplements for veterinary purposes; liquid hematinic nutritional supplemental preparations for animals; veterinary preparations for treating anxiety and central nervous system disorders in companion animals; oral animal feed supplements; dietary supplements veterinary purposes; oral re-hydration product for veterinary use, namely, oral rehydration salts; high calorie liquid diet for use as meal replacement, namely, meal replacement beverages adapted for veterinary use; none of the foregoing including or related to topical anesthetics, dental bite registration materials, materials for crowns and bridges for dental use, endodontic medicaments, hemostatic solution for dental use, dental impression materials, hemp seed oil in drops for use as a dietary supplement, hemp seed extract for medical and pharmaceutical use, hemp seed oil gummies for use as a dietary supplement, medicated hemp seed oil lip balm, nutritional supplements in the form of hemp seed oil gummies, fish oil for use as a dietary supplement, balms for medical purposes, balms for pharmaceutical purposes, analgesic balm, antibiotic creams, aromatherapy creams for treating headaches, relieving stress, curing insomnia, dietary and nutritional supplements containing hemp seed oil, fish oil, mushroom oil, dietary supplements in the form of capsules, liquid and powder, dietary supplements in the nature of weight loss powders, edible fish oils for medical purposes, gels, creams and solutions for dermatological use, medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, vitamin drops, cod-liver oil dietary supplement drops, medical diagnostic test strips for urine analysis, intestinal support dietary and nutritional supplements, liquid zinc supplement drops, testosterone booster supplements, glucosamine, turmeric dietary supplements, curcumin dietary supplements, dietary supplements for liver detox, prebiotic, probiotic in the form of drops, capsules, tablets and compressed tablets, elderberry drops for use as a dietary supplement, iodine drops, or medicinal drops to promote lactation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 9, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePegasus Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShawnee, KS 66226

Party NamePegasus Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShawnee, KS 66226

Trademark Events


Event DateEvent Description
Wednesday, October 9, 2024NEW APPLICATION ENTERED
Thursday, April 10, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 12, 2025ASSIGNED TO EXAMINER
Thursday, April 24, 2025NON-FINAL ACTION WRITTEN
Thursday, April 24, 2025NON-FINAL ACTION E-MAILED
Thursday, April 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 9, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, July 9, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, October 24, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 24, 2025EXAMINERS AMENDMENT -WRITTEN
Monday, November 24, 2025EXAMINERS AMENDMENT E-MAILED
Monday, November 24, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 24, 2025EXAMINER'S AMENDMENT ENTERED
Monday, November 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 17, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 23, 2025PUBLISHED FOR OPPOSITION
Tuesday, December 23, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED